Arun Bondali v. Yum! Brands, Inc.

620 F. App'x 483
CourtCourt of Appeals for the Sixth Circuit
DecidedAugust 20, 2015
Docket15-5064
StatusUnpublished
Cited by21 cases

This text of 620 F. App'x 483 (Arun Bondali v. Yum! Brands, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Arun Bondali v. Yum! Brands, Inc., 620 F. App'x 483 (6th Cir. 2015).

Opinion

McKEAGUE, Circuit Judge.

In this securities class action, investors sued Yum! Brands, Inc. (“Yum”), a public *485 ly traded corporation which owns restaurant chains Taco Bell and Kentucky Fried Chicken (“KFC”)- The investors also sued three of Yum’s senior officers: CEO David C. Novak, Richard T. Carucci, and Jing-Shyh Su. In their amended complaint, the investors allege that Yum and its senior officers knew batches of chicken being supplied to Yum’s KFC China subsidiary 1 had tested positive for drug and antibiotic residues and that Yum’s food standards and safety protocols were ineffective and also inadequate. The thrust of the amended complaint is that it was false or misleading for Yum not to disclose the adverse results and system failures to the public, the result of which was a 17 percent drop in stock price after the media began exposing the issues. The district court dismissed the amended complaint for failure to state a claim on which relief could be granted. For the reasons below, we affirm.

I.

Between 2010 and 2011, Yum received a series of test results from the Shanghai Institute for Food and Drug Control (“SIFDC”). The SIFDC is an independent laboratory Yum retained to conduct bimonthly spot testing on the chickens it accepted for distribution to its Chinese KFCs. The results showed that eight of nineteen batches of' chicken from one supplier, the Shandong Liuhe Group (“Liuhe”), had tested positive for drug and antibiotic residues prohibited under Chinese law. (R. 72, Page ID # 650.) In a December 2012 statement, Yum reported that, after receiving the test results in 2011, it disqualified the Linyi Factory (“Li-nyi”), a Liuhe subsidiary, identifying Linyi as “the factory saddled with the major problems.” In that same statement, Yum also explained that, in August 2012, it also disqualified Liuhe. (R. 72-11, Page ID # 827.)

Yum, however, did not immediately disclose the SIFDC results or disqualifications of Liuhe and Linyi to regulators or the public. Moreover, Yum did not immediately disclose that, in 2010, it learned of another supplier’s poultry — the Yingtai Group — also testing positive for drug and antibiotic residues. (R. 72, Page ID # 672.) 2

Indeed, Yum did not publicly acknowledge any issues with drug or antibiotic residues until the media began reporting on the issues in late 2012. The first media report mentioned in the amended complaint is a November 23, 2012 Bloomberg News article. It suggested that another supplier, the Shanxi Suhai Group, was using hormones to increase the size of its chickens. (See id. at Page ID # 711.) The most comprehensive media report aired on December 18, 2012 on Chinese Central Television (“CCTV”). That report suggested that Yum’s issues with food safety went beyond a single supplier. Rathfer, several farmers in Shandong Province, including farmers selling to Liuhe and Yingtai, were feeding their poultry antibiotics and other drugs to increase the chickens’ size and reduce the chickens’ mortality rates. (See R. 72-18, Page ID # 895-897.) CCTV also reported that farmers were not maintaining the legally *486 required “feeding journals” and that suppliers like Liuhe were fabricating their inspection and quarantine certificates to show there were no drug residues in the chicken. (See id. at Page ID # 899-900.)

The day after the CCTV report aired, Chinese regulators “raided, ransacked, then shuttered several farms and plants that had supplied chicken to KFC.” Yum’s stock price also declined 2.7 percent. (See id. at Page ID # 717.) By the end of the Class Period, Yum stock had “f[a]ll[en] nearly 17% from $74.47 per share on November 29, 2012, to $68.08 per share on February 5, 2018.” (Id. at Page ID # 720.) February 5, 2013 — the day after the close of the Class Period — was, according to the- plaintiffs, the day on which “the truth was fully revealed” by Yum admitting that: “Due to continued negative same-store sales and [Yum’s] assumption that it will take time to recover consumer confidence, we no longer expect to achieve [earnings per share] growth in 2013.” (Id. at Page ID # 676).

The plaintiffs allege the market’s negative response to the .media reports was unsurprising, 'given first the “hypersensitive” nature of Chinese consumers to food contamination issues, (see R. 72, Page ID # 634), and second the consumer backlash that has followed previous food safety issues at Yum. For example, in 2005, news that Chinese KFCs were using Sudan Red Dye, “a known and prohibited carcinogen,” caused “Yum’s sales to drop immediately and remain depressed for months.” (See id. at Page ID # 634.) Likewise, in 2007, Yum’s “reputation, and bottom line ... took a severe hit when E.coli was found in food sold by several Taco Bell restaurants in the U.S.” (See id.)

II.

The cases forming this class action were consolidated on May 1,2013. An amended complaint on behalf of the consolidated class was filed on August 5, 2013, contan-ing three counts: Count I alleged that Yum violated Section 10(b) of the 1934 Securities Exchange Act, 15 U.S.C. § 78j(b), and SEC Rule 10b-5, 17 C.F.R. § 240.10b-5; Count II alleged Section 10(b) and Rule 10b-5 liability against the individual defendants; and Count III alleged controlling-person liability against the individual defendants under Section 20(a) of the 1934 Securities Exchange Act, 15 U.S.C. § 78t(a). On October 14, 2013, the defendants filed a motion to dismiss pursuant to Federal Rule-of Civil Procedure 12(b)(6), and on December 23, 2014, the district court granted the motion, dismissing all three counts with prejudice.

The amended complaint avers that during the Class Period, the defendants made ten materially false or misleading statements. These statements can be divided into four categories. 3

Cautionary Statements or Risk Disclosures. The defendants made statements on the investment risk that food safety issues posed. One appears in each of Yum’s Earnings Announcements and 10-Qs during the Class Period:

• Our forward-looking statements are subject to risks and uncertainties, which may cause actual results to differ materially from those projected. Factors that can cause our actual results to differ, materially include, but *487 are not limited to: food borne-illness or food safety issuesf] (R. 72, Page ID # 701.)

The other appears in the “Risk Factors” section of Yum’s 2011 Form 10-K:

• [F]ood safety issues have occurred in the past, and could occur in the future.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
620 F. App'x 483, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arun-bondali-v-yum-brands-inc-ca6-2015.